One possible approach to limit the immunosuppressive tumor microenvironment is to inhibit vascular endothelial growth factor, as inhibition of VEGF not only normalizes tumor vessels in both human and mouse models, but also improves the delivery of CD8 positive T cells and the effectiveness of immunotherapies. This evidence concerns the gene VEGFA and neoplasm.